GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹33 Cr | ₹14 Cr | ₹14 Cr | ₹20 Cr | ₹31 Cr |
What is the latest Capital Work in Progress ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹33 Cr |
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹31 Cr |
How is Capital Work in Progress of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹33 Cr | 129.93 | |
| Mar2025 | ₹14 Cr | 2.80 | |
| Mar2024 | ₹14 Cr | -31.42 | |
| Mar2023 | ₹20 Cr | -33.41 | |
| Mar2022 | ₹31 Cr | - | |
Compare Capital Work in Progress of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,175.5 Cr | -1.8% | -11.1% | -6.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -1.8% |
-11.1% |
-6.8% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses